COVID-19 Vaccination Intentions, Concerns, and Facilitators Among US Parents of Children Ages 6 Months Through 4 Years.
COVID-19 Vaccination Intentions, Concerns, and Facilitators Among US Parents of Children Ages 6 Months Through 4 Years.
复制标题
DOI：
10.1001/jamanetworkopen.2022.27437
复制
发表时间：
2022-08-01
影响因子：
13.8
通讯作者：
Lindley, Megan C.
中科院分区：
文献类型：
--
作者：
Scherer, Aaron M.;Gidengil, Courtney A.;Gedlinske, Amber M.;Parker, Andrew M.;Askelson, Natoshia M.;Woodworth, Kate R.;Petersen, Christine A.;Lindley, Megan C.
父母对6个月至4岁儿童接种COVID-19疫苗的意图、担忧和促进因素是什么？在这项针对2031名有6个月至4岁儿童的美国成年人的横断面研究中，一半的人表示他们打算在某个时候给孩子接种COVID-19疫苗，但只有五分之一的人打算在孩子合格后的3个月内接种。该年龄组接种COVID-19疫苗的最大担忧和促进因素与COVID-19疫苗接种的安全性和有效性有关。这些发现表明，可能需要做出相当大的努力来提高父母对6个月至4岁儿童的COVID-19疫苗信心，以最大限度地为该年龄组接种COVID-19疫苗。这项横断面研究评估了6个月至4岁儿童的父母是否打算为他们的孩子接种COVID-19疫苗，以及与决定接种该年龄组疫苗相关的担忧或促进因素。6个月至4岁的儿童已具备接种COVID-19疫苗的资格，但对父母对该年龄组COVID-19疫苗接种的意图、担忧或促进因素知之甚少。评估父母对6个月至4岁儿童接种COVID-19疫苗的意向、担忧和促进者，并帮助告知美国疾病控制和预防中心免疫实践咨询委员会对6个月至4岁儿童接种COVID-19疫苗的审议和建议。这项横断面研究于2022年2月2日至10日进行了一项在线调查，调查对象是6个月至4岁儿童的美国父母的非概率样本，这些父母通过Qualtrics招募，使用基于配额的抽样调查受访者性别，种族和民族以及儿童年龄组。COVID-19疫苗接种意向、接种COVID-19疫苗的时间、COVID-19疫苗接种问题和促进者，以及6个月至4岁儿童的可信赖的COVID-19疫苗接种地点。2031名参与者的最终加权样本（73.5%的参与率）有更多的受访者认为自己是男性（985;加权百分比，54.8%）或白色（696;加权百分比，66.2%），年龄为25至49岁（1628人;加权百分比，85.6%），至少拥有学士学位（711人;加权百分比，40.0%），居住在大都市地区（1743;加权百分比，82.9%）或南方（961;加权百分比，43.4%），或至少接受了一剂COVID-19疫苗（1205;加权百分比，59.8%）。一半的受访者（645;加权百分比，45.6%）表示，他们“肯定”或“可能”将接种他们的孩子年龄从6个月到4岁，一旦他们成为合格的。然而，只有五分之一（396;加权百分比，19.0%）的人表示，他们将在符合接种条件的3个月内为这个年龄组的孩子接种COVID-19疫苗。疫苗的安全性和有效性是家长最关心的问题，获得更多有关安全性和有效性的信息是该年龄组接种COVID-19疫苗的最大促进因素。医生办公室或诊所以及当地药房是该年龄组最值得信赖的COVID-19疫苗接种地点。这些结果表明，只有少数该年龄段儿童的父母渴望在符合条件的最初几个月内为孩子接种疫苗，人们普遍担心该年龄段的COVID-19疫苗接种。因此，可能需要付出相当大的努力来提高父母对6个月至4岁儿童的COVID-19疫苗信心，以最大限度地为美国该年龄段的儿童接种COVID-19疫苗。
What are parents’ intentions, concerns, and facilitators to COVID-19 vaccination for their children aged 6 months through 4 years? In this cross-sectional study of 2031 US adults with children aged 6 months through 4 years, half indicated they intended to get their child a COVID-19 vaccine at some point, but only one-fifth intended to do so within 3 months of the child’s eligibility. The top concerns about and facilitators to COVID-19 vaccination for this age group related to COVID-19 vaccination safety and efficacy. These findings suggest that considerable efforts to increase parental COVID-19 vaccine confidence for children aged 6 months through 4 years may be needed to maximize COVID-19 vaccination for this age group. This cross-sectional study evaluates whether parents of children aged 6 months through 4 years intend to vaccinate their children against COVID-19 and what concerns or facilitators are associated with the decision to vaccinate this age group. Children aged 6 months through 4 years have become eligible for COVID-19 vaccination, but little is known about parental intentions regarding, concerns about, or facilitators to COVID-19 vaccination for this age group. To evaluate parental intentions, concerns, and facilitators for COVID-19 vaccination for children aged 6 months through 4 years and to help inform the US Centers for Disease Control and Prevention Advisory Committee on Immunization Practices’ deliberations and recommendations for COVID-19 vaccination for children aged 6 months through 4 years. This cross-sectional study fielded an online survey from February 2 to 10, 2022, among a nonprobability sample of US parents of children aged 6 months through 4 years who were recruited through Qualtrics using quota-based sampling for respondent gender, race and ethnicity, and child age group. COVID-19 vaccination intentions, time to COVID-19 vaccination, COVID-19 vaccination concerns and facilitators, and trusted COVID-19 vaccination locations for children aged 6 months through 4 years. The final weighted sample of 2031 participants (73.5% participation rate) had more respondents who identified as male (985; weighted percentage, 54.8%) or White (696; weighted percentage, 66.2%), were aged 25 to 49 years (1628; weighted percentage, 85.6%), had at least a bachelor’s degree (711; weighted percentage, 40.0%), lived in a metropolitan area (1743; weighted percentage, 82.9%) or the South (961; weighted percentage, 43.4%), or received at least 1 dose of a COVID-19 vaccine (1205; weighted percentage, 59.8%). Half of respondents (645; weighted percentage, 45.6%) indicated that they “definitely” or “probably” will vaccinate their child aged 6 months through 4 years once they became eligible. However, only one-fifth (396; weighted percentage, 19.0%) indicated they would get a COVID-19 vaccine for their child in this age group within 3 months of them becoming eligible for vaccination. Vaccine safety and efficacy were parents’ top concerns, and receiving more information about safety and efficacy were the top facilitators to COVID-19 vaccination for this age group. A doctor’s office or clinic and local pharmacy were the most trusted COVID-19 vaccination locations for this age group. These results suggest that only a minority of parents of children in this age group are eager to vaccinate their children within the first few months of eligibility, with widespread concerns about COVID-19 vaccination for this age group. Thus, considerable efforts to increase parental COVID-19 vaccine confidence for children aged 6 months through 4 years may be needed to maximize COVID-19 vaccination for this age group in the United States.
登录
查看更多内容
在美国，家长/监护人打算为儿童接种 COVID-19 疫苗。
影响因子：
4.8
作者：
通讯作者：
--
影响因子：
8
作者：
Szilagyi, Peter G.;Shah, Megha D.;Delgado, Jeanne R.;Thomas, Kyla;Vizueta, Nathalie;Cui, Yan;Vangala, Sitaram;Shetgiri, Rashmi;Kapteyn, Arie
通讯作者：
Kapteyn, Arie
DOI：
10.15585/mmwr.mm7111e2
发表时间：
2022-03-18
期刊：
MMWR. Morbidity and mortality weekly report
影响因子：
--
作者：
Marks KJ;Whitaker M;Agathis NT;Anglin O;Milucky J;Patel K;Pham H;Kirley PD;Kawasaki B;Meek J;Anderson EJ;Weigel A;Kim S;Lynfield R;Ropp SL;Spina NL;Bennett NM;Shiltz E;Sutton M;Talbot HK;Price A;Taylor CA;Havers FP;COVID-NET Surveillance Team
通讯作者：
COVID-NET Surveillance Team
DOI：
10.1016/j.jpeds.2021.07.021
发表时间：
2021-10
期刊：
The Journal of pediatrics
影响因子：
--
作者：
Teasdale CA;Borrell LN;Kimball S;Rinke ML;Rane M;Fleary SA;Nash D
通讯作者：
Nash D